Graham T. Watson

Graham T. Watson

Hematology | Oncology
6251 E Virginia Beach Blvd
Norfolk, VA 23502

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Phase II Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1-Pretreated Metastatic Non-Small Cell Lung Cancer and Metastatic Cutaneous Melanoma.

Phase II Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1-Pretreated Metastatic Non-Small Cell Lung Cancer and Metastatic Cutaneous Melanoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 15, 2024
Showing 1-1 of 1

Last Updated: 09/26/2026